Bright Cloud International (BCI) receives a Phase I Small Business Innovation Research Award from the National Institutes of Health/National Institute on Drug Abuse (NIDA). The grant will allow BCI to develop a non-pharmaceutical therapy for cancer survivors who suffer from chronic upper body pain. The therapy, based on BCI’s BrightArm™ computerized rehabilitation system, will be developed and tested in partnership with the Cancer Institute of New Jersey (UMDNJ), and Roosevelt Care Center.
- BCI Unveils the New BrightBrainer BBX at American Congress of Rehabilitation Medicine (ACRM) 2017 in Atlanta
- Dr. Grigore Burdea, BCI President, received the Virtual Reality Career Award
- BCI will be exhibiting at the AOTA 100th Annual Conference in Philadelphia March 30 to April 1
- BCI sponsors ICDVRAT 2016 Best Paper and Best Short Paper Awards, September 2016